1. 夏景松，蒋熙，邹文斌，等.慢性胰腺炎药物治疗研究进展[J].中华消化杂志，2023，43（12）：848-852.
2. Poulsen JL, Olesen SS, Malver LP, et al. Pain and chronic pancreatitis: a complex interplay of multiple mechanisms [J].World J Gastroenterol, 2013,19(42):7282-7291.
3. Zhou D, Wang W, Cheng X, et al. Antioxidant therapy for patients with chronic pancreatitis: a systematic review and meta-analysis[J]. Clin Nutr, 2015,34 (4):627-634.
4. Olesen SS, Bouwense SA, Wilder-Smith OH, et al. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial[J]. Gastroenterology, 2011,141 (2):536-543.
5. Gardner TB, Adler DG, Forsmark CE, et al. ACG clinical guideline: chronic pancreatitis [J]. Am J Gastroenterol, 2020,115(3):322-339.
6. Dominguez-Munoz JE, Iglesias-Garcia J, Iglesias-Rey M, et al.Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts[J]. Gut, 2006, 55(7): 1056-1057.
7. Han C, Wang LJ, Dong ZQ, et al. Nintedanib alleviates chronic pancreatitis by inhibiting the activation of pancreatic stellate cells via the JAK/STAT3 and ERK1/2 pathways [J]. Dig Dis Sci,2023,68(9) :3644-3659.
8. Zeng XP, Wang LJ, Guo HL, et al. Dasatinib ameliorates chronic pancreatitis induced by caerulein via anti-fibrotic and anti-inflammatory mechanism [J/OL]. Pharmacol Res, 2019, 147:104357.
